Pharmacy Report Archives - Page 121 of 150 - Becker's Hospital Review

Henry Ford defends study, slams politicization of hydroxychloroquine | Sanofi, GSK under investigation for Zantac | 10 best, worst states for healthcare | Amazon's PillPack partners with Horizon, Prime Therapeutics

August 4, 2020 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Henry Ford researchers defend hydroxychloroquine study, slam politics surrounding drug Full story 2. Sanofi, GlaxoSmithKline under investigation for possible carcinogen in Zantac Full story 3. Amazon's PillPack partners…

Ohio reverses hydroxychloroquine ban | 10 most expensive Part B drugs | Appeals court: 340B payment cuts are legal | Sanofi, GSK get up to $2.1B from US for COVID-19 vaccine | Chinese hackers allegedly targeted Moderna's COVID-19 research

August 3, 2020 BHR Newsletter Virtual Events • Webinars • Recent Whitepapers • Podcasts 1. Ohio pharmacy board reverses hydroxychloroquine ban Full story 2. Moderna's coronavirus vaccine research alleged target of Chinese hackers Full story 3. US to pay Sanofi, GlaxoSmithKline up to $2.1B…

Ohio first state to ban hydroxychloroquine for COVID-19 | US to send Texas 500 cases of remdesivir | Hospitals to spend 3.29% more on drugs in 2021 | Operation Warp Speed: A timeline

July 30, 2020 BHR Newsletter Virtual Events • Webinars • Recent Whitepapers • Podcasts 1. Ohio's board of pharmacy bans hydroxychloroquine for use in COVID-19 patients Full story 2. Hospitals will spend 3.29% more on drugs in 2021, Vizient projects Full story 3. US…

Patient data potentially exposed at 180 Walgreens stores | 10 best-selling drugs globally by 2026 | Kodak gets $765M to make APIs | FDA puts hand sanitizers on import alert

July 29, 2020 BHR Newsletter Virtual Events • Webinars • Recent Whitepapers • Podcasts 1. Walgreens says 180 stores affected by potential patient data breach Full story 2. Kodak gets $765M loan to make APIs under Defense Production Act Full story 3. 10 best-selling…

Moderna, Pfizer start late-stage COVID-19 vaccine trials | These 20 hospitals top US News' Honor Roll | CVS loses 21K patients' info after vandalism | Drug lobbies don't show for White House meeting

July 28, 2020 BHR Newsletter Virtual Events • Webinars • Recent Whitepapers • Podcasts 1. Moderna, Pfizer begin late-stage COVID-19 vaccine trials Full story 2. CVS Pharmacy loses 21,289 patients' information after vandalism Full story 3. Indivior pleads guilty, agrees to pay $600M to…

Walgreens CEO steps down | Trump signs 4 drug pricing orders | AstraZeneca inks $6B cancer drug deal | 6 pharma leaders on how COVID-19 affected medication adherence

July 27, 2020 BHR Newsletter Virtual Events • Webinars • Recent Whitepapers • Podcasts 1. Trump signs 4 executive orders targeting drug prices: 6 things to know Full story 2. Walgreens CEO steps down Full story 3. AstraZeneca, Daiichi Sankyo partner in $6B cancer…

Fresenius Kabi recalls sedative | Biogen CFO steps down | 10 drugmakers expected to be most profitable in 5 years | DEA rules leave hospitals short on IV opioids, Premier says

July 23, 2020 BHR Newsletter Virtual Events • Webinars • Recent Whitepapers • Podcasts 1. Fresenius Kabi recalls sedative, cites possible cross-contamination Full story 2. 10 drugmakers expected to make the most money in the next 5 years Full story 3. DEA rules leave…

US inks $1.95B vaccine distribution deal with Pfizer, BioNTech | FDA: 20 more hand sanitizers may be toxic | 'Enough is enough': APhA wants revamp of pharmacy reimbursements | 10 most valuable pharma R&D projects

July 22, 2020 BHR Newsletter Virtual Events • Webinars • Recent Whitepapers • Podcasts 1. 'Enough is enough': APhA CEO calls for pharmacy reimbursement overhaul Full story 2. 10 most valuable R&D projects in the pharmaceutical industry pipeline Full story 3. Pfizer, BioNTech sign…

3 COVID-19 vaccine makers report positive results | Walgreens names CTO | How COVID-19 affected sales at top 15 drugmakers | 2-dose COVID-19 vaccine may complicate immunization efforts

July 21, 2020 BHR Newsletter Virtual Events • Webinars • Recent Whitepapers • Podcasts 1. Two-dose COVID-19 vaccines could complicate efforts to immunize billions of people Full story 2. Walgreens Boots Alliance appoints new chief technology officer Full story 3. AstraZeneca, U of Oxford…

NIH updates remdesivir guidelines | CVS fined for understaffing, prescription errors | 5 provisions pharmacists want in Congress' next relief package | Novartis to supply COVID-19 drugs to low-income countries

July 20, 2020 BHR Newsletter Virtual Events • Webinars • Recent Whitepapers • Podcasts 1. NIH updates remdesivir treatment guidelines Full story 2. J&J to start human trials of its COVID-19 vaccine this week Full story 3. CVS fined for understaffing, prescription errors in…